Nova Leap Health stock analysis
Want to see TSE:NLH full AI Analyst Report?
Nova Leap Health (NLH) Stock Price & Analysis
NLH Stock Chart & Stats
- Day’s Range
- CAD 0.48 - CAD 0.49
- 52-Week Range
- CAD 0.27 - CAD 0.60
- Previous Close
- CAD 0.49
- Volume
- N/A
- Average Volume (3M)
- 8,638
- Market Cap
- CAD 42.61M
- Enterprise Value
- CAD 49.23M
- Total Cash (Recent Filing)
- CAD 1.93M
- Total Debt (Recent Filing)
- CAD 4.39M
- Price to Earnings (P/E)
- 24.5
- Beta
- 0.32
- Next Earnings
- Mar 11, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Improving Profitability
TTM profitability has recovered after the 2025 loss, while EBIT margin also improved. If maintained, this stronger earnings base can support reinvestment and improve operating resilience, although the evidence reflects a recent recovery rather than a long record of consistency.
Free Cash Flow Generation
Positive and growing free cash flow gives Nova Leap internally generated funds to support operations, investment, and potential expansion without relying as heavily on external financing. FCF roughly matching net income also indicates that recent earnings are being converted into cash.
Low Financial Leverage
Low leverage provides financial flexibility for a home-care platform operating through multiple service locations. A comparatively equity-funded balance sheet reduces debt pressure and leaves more capacity to absorb operating variability or fund measured growth over the coming quarters.
Bears Say
Earnings Volatility
The return to profit is encouraging, but repeated losses and large historical margin swings show that earnings power has not yet demonstrated consistent durability. This volatility makes future profitability less predictable and could limit confidence in sustained returns over the medium term.
Uneven Revenue Growth
Recent revenue growth is positive but modest, and the stated unevenness suggests that expansion has not followed a consistently dependable trajectory. Slower or irregular top-line growth can constrain operating leverage, reduce visibility for planning, and make margin improvement harder to sustain.
Variable Cash Conversion
Although current free cash flow is strong, the history of sub-1.0x cash-flow coverage indicates that earnings have not converted consistently into cash. Variability in cash conversion and working-capital dynamics could reduce the reliability of internally funded growth and financial flexibility.
Nova Leap Health News
NLH FAQ
What was Nova Leap Health’s price range in the past 12 months?
What is Nova Leap Health’s market cap?
When is Nova Leap Health’s upcoming earnings report date?
How were Nova Leap Health’s earnings last quarter?
Is Nova Leap Health overvalued?
Does Nova Leap Health pay dividends?
What is Nova Leap Health’s EPS estimate?
How many shares outstanding does Nova Leap Health have?
What happened to Nova Leap Health’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Nova Leap Health?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Nova Leap Health
Nova Leap Health Corp. delivers a comprehensive array of in-home and healthcare-at-home solutions across the United States and Canada. Their offerings encompass specialized dementia support, social companionship, assistance with personal needs, and temporary relief for family caregivers. They additionally manage household tasks such as cooking, meal preparation, cleaning, running errands, and providing transportation. Crucially, qualified nursing personnel provide medication reminders. Established in 2015, Nova Leap Health Corp. maintains its primary operations base in Halifax, Canada.
- Sector
- General
- Industry
- Medical - Care Facilities
- CEO
- Christopher Donald Dobbin
- Employees
- 541
- Website
- novaleaphealth.com
- Address
- 7071 Bayers Road, Halifax, NS, B3L 2C2, CA
Nova Leap Health (NLH) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 4 | 3 |
| Technical Analysis | 4 | 4 | 2 |
| Moving Averages | 11 | 0 | 1 |







